No Prescription |
 |
 | ||
|
FIBRAL Antara |
|
| ||
No Prescription » Prescription Drugs 7 » FIBRAL Antara Fenofibrate is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and triglycerides (fatty substances) in your blood. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and therefore the oxygen supply to your heart brain and other parts of your body. Lowering your blood level of cholesterol and fats may help to prevent heart disease angina (chest pain) strokes and heart attacks.Fenofibrate comes as a capsule to take by mouth. It is usually taken once a day with a meal. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take fenofibrate exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Buy FIBRAL Antara and other Prescription Drugs 7 products online at Medstore. 427
About FIBRAL Antara: Product Type: Prescription Drugs 7 FIBRAL ( Antara Lofibra Tricor Triglide Generic Fenofibrate ) FIBRAL (Antara Lofibra Tricor Triglide Generic Fenofibrate) Antara Lofibra Tricor Triglide Generic Fenofibrate 200 mg Caps 100 (10 x 10) Antara Lofibra Tricor Triglide Generic Fenofibrate FIBRAL
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
